
**Centre for Osteopathic Research and Excellence (A CIO governed by its constitution, charity number 1166246)** 

## **Financial Statements and Trustees’ Report** 

## **for the year ended 31 December 2025** 

Company number: CE006067 Charity number: 1166246 

**1** 



(A CIO governed by its constitution, charity number 1166246) 

## Centre for Osteopathic Research and Excellence 

## Index to the Financial Statements 

for the year ended 31 December 2025 

|Index to the Financial Statements<br>Charity Information<br>Trustees’ Report<br>Statement of Trustees’ Responsibilities<br>Independent Examiner’s Report<br>Statement of Financial Activities<br>Statement of Financial Position<br>Statement of Cash Flows<br>Accounting Policies<br>Notes to the Accounts|2<br>3<br>4 - 6<br>7<br>8<br>9<br>10<br>11<br>12<br>13-17|
|---|---|



**2** 



## Centre for Osteopathic Research and Excellence 

(A CIO governed by its constitution, charity number 1166246) 

## Charity Information 

for the year ended 31 December 2025 

|Status:|Centre for Osteopathic Research and Excellence is a charitable incorporated|
|---|---|
||organisation (CIO) governed by its constitution and registered with the Charity|
||Commission for England and Wales under number 1166246|
|Charity name:|Centre for Osteopathic Research and Excellence|
|Other operating names:|CORE / Core Clapton|
|Charity registration number:|1166246|
|Registered ofce:|161 Northwold Road|
||London|
||E5 8RL|
|Operation addresses:|161 Northwold Road|
||London|
||E5 8RL|
||&|
||Yonder|
||6 Hooker’s Rd|
||London|
||E17 6DP|
|Trustees who held ofce during the period|Shruthi John (Chair)|
|to the date of these accounts:|Peter Sharp|
||Ash Bavalia,(Rejoined August 2025)|
||Michelle Gallacher (Stepped down August 2025)|
||Daniel Orchard (Stepped down August 2025)|
||Tessa Dwyer (Treasurer - stepped down June 2026)|
||Julia Jones (Stepped down September 2026)|
|Independent Examiner:|Lucy Clark (CA)|
||7 Branch Road|
||London|
||E14 7JZ|
|Solicitors:|Paul Hastings|
||100 Bishopsgate|
||London EC2N 4AG|
|Bankers:|The Co-operative Bank plc|
||PO Box 101|
||1 Balloon Street|
||Manchester M60 4EP|



**3** 



## Centre for Osteopathic Research and Excellence 

(A CIO governed by its constitution, charity number 1166246) 

## Trustees’ Report 

for the year ended 31 December 2025 

The trustees present their annual report and financial statements of the Centre for Osteopathic Research and Excellence (CORE or Core Clapton), a charitable incorporated organisation, for the year ended 31 December 2025. The financial statements are prepared in accordance with applicable UK accounting requirements and the Charities SORP (Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland). 

## **Activities** 

CORE believes that everyone should have access to compassionate, effective support for pain and physical wellbeing, regardless of income. From our community-based services in East London, we combine osteopathic care, movement and education to help people manage pain, restore confidence and participate more fully in everyday life. 

Our approach recognises that persistent pain is influenced by physical, psychological and social circumstances and that meaningful care requires time, understanding and practical support. 

## **Structure, Governance and Management** 

The Board of Trustees meets on a quarterly basis to oversee strategy, charitable activities, staffing, finance and risk. New trustees are introduced to the organisation through meetings with existing board members and receive its constitution, latest accounts, strategic objectives and the Charity Commission’s guidance, The Essential Trustee. Trustees are recruited through community networks and relevant external organisations, with attention to the skills and lived experience needed to support CORE’s mission. [DK2.1] Incoming Trustees are approved by all members of the Board. 

Daniel Orchard and Michelle Gallacher stepped down as trustees on 5 August, 2025 while Ash Bavalia, one of the founding Trustees, rejoined the Board for a second term. Daniel Orchard continued as CEO. Following the reporting year, Tessa Dwyer stepped down from the Board on 15 June 2026 and Dan Khan joined and took on her role as Treasurer having previously supported CORE as a volunteer for several years. Julia Jones also stepped down on 22 September 2026. These subsequent changes will be reflected in the charity information accompanying the accounts. 

## **Supporters** 

We are grateful to the patients, class participants, venue hirers, volunteers, clinicians, partner organisations and donors whose support makes our charitable work possible. In 2025, Jonny White, founder of Ticket Tailor and a longstanding supporter of CORE, made a particularly generous £15,000 contribution. 

We also benefited from £26,000 of funding split over 2025 (10/12) and 2026 (2/12) through the ARC North Thames Mental Health for All (MH-ALL) programme to support our director’s fellowship work on chronic pain and touch. 

## **Governing Document** 

CORE is a charitable incorporated organisation governed by its constitution dated 14 March 2016, which sets out its charitable objects and powers. 

## **Risk Management** 

The Board of Trustees maintains oversight of strategic, financial and operational risks through board review, financial monitoring, internal cont ~~rols and the charity’s risk register. In 2025, uncertainty surrounding the long-term occupation of the Clapto~~ n premises remained a significant risk, affecting forward planning and the ability to secure longer-term venue bookings. The charity continued to operate on a rent-free basis while exploring sustainable premises arrangements. The Board also monitored income diversification, service capacity, staffing and the commitments associated with delivering subsidised care. 

## **OUR MISSION** 

CORE works to make osteopathy and supportive approaches to pain management accessible to all, while contributing to research, education and professional excellence. We provide care through an income-based fee structure, fully funded community pathways and accessible wellbeing activities. Our mission is to widen access, strengthen communities, improve the evidence base for care and uphold high clinical standards. 

## **Our Beneficiaries** 

Core Clapton supports people from across Hackney and beyond, including those living with persistent pain, reduced mobility, social isolation and financial insecurity. In 2025, 59% of patients were recorded as belonging to BAME communities; 66% identified as female and 7% as non-binary or trans. A further 21% were unemployed or unable to work because of illness or caring responsibilities. These figures underline the importance of maintaining services that are affordable, welcoming and responsive to different circumstances. 

**4** 



## Centre for Osteopathic Research and Excellence 

(A CIO governed by its constitution, charity number 1166246) 

## Trustees’ Report 

for the year ended 31 December 2025 

## **What We Do** 

## **C is for Community. We raise awareness of osteopathy and strengthen community wellbeing.** 

Across CORE’s services in 2025, 1,479 clients received 4,782 treatment appointments: 3,998 osteopathic appointments and 784 appointments for other therapies. The osteopathic service supported 1,127 patients, including 836 new patients who attended an initial appointment. Since 2017, CORE has seen 6,398 clients and delivered 33,136 treatments, including 11,386 low-income treatments. 

Our community pain pathway, developed with social prescribers and other local referral partners, resumed in September 2025 after a pause. This allowed CORE to renew a vital route into care for people with complex persistent pain who are out of work because of their condition and may face multiple barriers to conventional services. 

## **Here are what some of our community have said about us:** 

“I had my first osteopathy appointment yesterday. I have to say my experience was utterly brilliant. I arrived embodied with anxiety and fairly emotional and left feeling overjoyed, happy and elated. Helen greeted and helped me negotiate the ramp with my walker. ( I struggle with mobility after a stroke). Appt with Anya brilliant. I slept better than I had for a few years post stroke. I am going to wiggle my limited budget to ensure I can go more than once a month. I would definitely recommend to anyone as a complementary therapy and experience to all stroke survivors on the road to thriving..” **Amanda C** 

“I highly recommend Core Clapton. The atmosphere is lovely, welcoming and professional, which put me at ease and made me feel comfortable. I have been seeing Nadia, an amazing osteopath, due to experiencing extreme tension in my shoulders and neck. After just the first visit, the tension and pain had significantly dissipated. Nadia took the time to carefully explain the treatment and provided me with exercises to do at home. She made sure I had clear guidance on what to do, which has been incredibly helpful. Core Clapton and Nadia both get 5 stars from me. I absolutely recommend visiting Core Clapton. Thank you, Nadia, for your firstclass service, guidance, and support. You have truly made a difference and have helped me immensely.” **Wendy G** 

## **O is for Osteopathy. We make osteopathy affordable and accessible to all.** 

During 2025 our osteopaths delivered 3,998 appointments, comprising 836 initial consultations and 3,162 follow-up appointments. Our income-based model enabled 136 patients to receive 1,122 means-tested concessionary treatments. Separately, 55 patients received 290 fully funded appointments through the social prescriber-led community pain programme, which supports people whose persistent pain has affected their ability to work. Together, these pathways provided 1,412 free or reduced-fee treatments (35.3% of all osteopathic appointments) helping ensure that cost is not the deciding factor in access to care. 

Care combines individualised assessment and hands-on treatment with explanation, reassurance, movement advice and supported self-management. The emphasis is on what matters to each person: improved confidence, greater participation and the ability to return to valued daily activities. 

## **R is for Research. We gather and publish osteopathy-focused research.** 

Research was a significant area of progress in 2025. In December, CORE’s first peer-reviewed article, reporting an earlier feasibility study of oste ~~opathic care for older adults living with chronic musculoskeletal pain, was published. This marked an imp~~ ortant milestone in our commitment to evaluating care delivered in community settings. 

(Orchard et al, 2025. The outcome of a short course of osteopathy for older adults with chronic musculoskeletal (MSK) pain. A single-arm, prospective feasibility study, International Journal of Osteopathic Medicine.) 

We also began planning a proof-of-concept study with East London NHS Foundation Trust (ELFT) service directors to explore osteopathy alongside body-oriented psychotherapy for patients experiencing chronic pain and bodily distress disorder. This collaboration aims to better understand the potential contribution of touch-based care within a multidisciplinary psychological service. 

Our work with Keele University continued as we developed the systems needed to contribute routine musculoskeletal patientreported outcome and experience data to the National MSK Audit. 

In parallel, CORE’s CEO, Daniel Orchard, began an ARC North Thames MH-ALL fellowship hosted at UCL, exploring patient and public perspectives on touch in chronic pain management. Together these strands strengthened CORE’s relationships with NHS, university and lived-experience partners and laid foundations for future evaluation. 

## **E is for Excellence. We raise the profile of osteopathy as a profession.** 

**5** 



## Centre for Osteopathic Research and Excellence 

(A CIO governed by its constitution, charity number 1166246) 

## Trustees’ Report 

## for the year ended 31 December 2025 

CORE continued to support reflective practice, peer learning and professional development. The Graduate Learning Programme resumed alongside the community pain referral pathway in September 2025, creating opportunities for early-career osteopaths to develop their clinical skills while contributing to access for people with complex needs. 

We also delivered our first Pain & Perception continuing professional development event for manual therapists, bringing contemporary pain science into clinical practice. CORE hosted osteopath Torsten Liem for a six-day course in psychosomatic osteopathy, reinforcing our role as a setting for specialist learning and exchange. 

## **Financial Review** 

The 2025 accounts record a substantial improvement in income and financial performance. Income from charitable activities rose to £246,434 (2024: £191,891), including £194,553 from osteopathy and £51,881 from other treatments. Trading income increased to £158,044 (2024: £119,048), including £108,791 from events, while grants and donations rose to £54,415 (2024: £13,868). The cashflow statement reports a £64,790 surplus for the year, compared with £4,397 in 2024. These improvements reflect stronger earned income and important philanthropic and research support. 

## **Financial Activity and Financial Position** 

The accounts report total income of £458,893 and expenditure of £394,102, subject to reconciliation of rounding and fund classification. At 31 December 2025, cash stood at £37,642 (2024: £5,436), current liabilities at £48,890, and liabilities due after more than one year at £37,608 (2024: £61,172). Net liabilities reduced to approximately £31,492 from approximately £96,283 on the comparative figures presented in the 2025. This represents meaningful progress in strengthening liquidity and reducing debt, although net funds remained negative. . 

## **Tangible fixed assets for use by the Charity** 

Tangible Fixed Assets are set out in Note 9 to the accounts. 

## **Reserves Policy** 

The trustees’ approach is to maintain sufficient accessible resources to meet essential obligations during periods of reduced income, including a reduced core staffing structure, key overheads and any restricted-fund or loan commitments. This proportionate policy reflects CORE’s operating model and the need to safeguard service continuity or, if required, an orderly winddown. At 31 December 2025 the accounts show negative total funds of £31,492 and cash of £37,642; accordingly, the charity has not yet established positive free reserves. The trustees continue to prioritise rebuilding resilience while maintaining essential services. 

## **Principal funding sources and how expenditure supports the Charity’s key objectives** 

CORE’s principal income streams continued to include osteopathy, complementary therapies, wellness activities, venue hire and voluntary support. These activities help meet the costs of running the charity and enable the delivery of means-tested and free clinical care. The £15,000 donation from Jonny White and £21,670 MH-ALL fellowship funding were important contributions during 2025. 

## **Going concern** 

Throughout 2025, CORE remained in its Clapton premises on a rent-free basis. Discussions with a potential incoming tenant did not result in a long-term arrangement, leaving the charity to continue planning around premises uncertainty. In autumn 2025, CORE also opened a clinic at Yonder in Walthamstow, establishing a complementary site with a developing focus on the physical needs of you ~~ng climbers.~~ 

Since the year-end, the charity has progressed negotiations for a new five-year lease for the Clapton premises. If completed, this would provide greater security for future service planning, although it would also introduce rental costs following the rent-free period. Management has included the anticipated rent and associated income and donation assumptions in forward projections. The trustees have assessed these forecasts, cash flows and available support for at least twelve months from the date the 2025 accounts were approved and confirm the going concern basis. 

## **Independent Examiner** 

The Independent Examiner for the 2025 accounts is Lucy Clark (CA). 

The financial statements were approved by the Board on 29th October 2026 and signed on its behalf by the Chair, Shruthi John. 


**6** 



## Centre for Osteopathic Research and Excellence 

(A CIO governed by its constitution, charity number 1166246) 

## Statement of Trustees’ Responsibilities 

for the year ended 31 December 2025 

The trustees are responsible for preparing the Trustees Annual Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). 

The trustees are required by law to prepare financial statements for each financial period which give a true and fair view of the financial activities of the Charity and of its financial position at the end of that period. In preparing those financial statements the trustees are required to: 

- a. Select suitable accounting policies and apply them consistently; 

- b. Observe the methods and principles in the Charities SORP; 

- c. Make judgements and estimates that are reasonable and prudent; 

- d. Follow applicable accounting standards and statements of recommended practice, subject to any material departures disclosed and explained in the accounts; 

- e. Prepare the financial statements on the going concern basis unless it is inappropriate to assume that the Charity will continue in operation. 

The trustees are responsible for maintaining proper accounting records which disclose with reasonable accuracy at any time the financial position of the Charity and to enable them to ensure that the financial statements comply with Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the governing document. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. The Trustees are responsible for the maintenance and integrity of the Charity and financial information included in the Charity’s website. 

**7** 



## Centre for Osteopathic Research and Excellence 

(A CIO governed by its constitution, charity number 1166246) 

## Independent Examiner’s Report 

for the year ended 31 December 2025 

I report on the accounts of Centre for Osteopathic Research and Excellence (“CORE Clapton”) for Year Ended 31st December 2025, which are set out on pages 1 to 17. 

This report is made solely to the Charity’s trustees as a body in accordance with section 145 of the Charities Act 2011 (“The Charities Act”) and regulations made under section 154. My examination has been undertaken so that I might state to the Charity’s trustees those matters I am required to state to them in an independent examiner’s report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the Charity’s trustees as a body, for my examination, for this report, or for the opinions I have formed. 

## **Respective Responsibilities of Trustees and the Independent Examiner** 

As detailed in the Trustees Report section, the trustees are responsible for the preparation of the accounts. The Charity’s trustees consider that an audit is not required for Year Ended 31st December 2025 under section 144 of The Charities Act, with an independent examination required instead as the Charity’s gross income has exceeded £250,000. I possess the correct qualifications and competencies to undertake the examination as a qualified member of the Institute of Chartered Accountants in Scotland (ICAS). 

Having satisfied myself that the Charity is not subject to audit under charity law and is eligible for independent examination, it is my responsibility to: 

1. Examine the Charity’s accounts under section 145 of The Charities Act, 

2. To follow procedures laid down in the general directions given by the Charity Commission under section 145(5)(b) of The Charities Act, and 

3. To state whether particular matters have come to my attention. 

## **Basis of independent Examiner’s Statement** 

My examination was carried out in accordance with the general directions given by the Charity Commission. An examination includes a review of the accounting records kept by the Charity and a comparison of the accounts presented with those records. It also includes further consideration for any unusual or key items, as well as disclosures in the accounts, and seeking explanations from the trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit, and consequently no opinion is given as to whether the accounts present a ‘true and fair view’ and the report is limited to those matters set out in the statement below. 

## **Independent Examiner’s Statement** 

Upon completion of the independent examination, no material matters have come to my attention which gives cause to believe that in, any material respect: 

1. The accounting records were not kept in accordance with section 130 of The Charities Act; or 

2. The accounts did not accord with the accounting records; or 

3. The accounts did not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a ‘true and fair’ view which is not a matter considered as part of an independent examination. 

I have not identified any matters during the examination to which attention should be drawn in this report. 

Lucy Clark (CA) 


**Dated: 30th October 2026** 

**8** 



## Centre for Osteopathic Research and Excellence 

(A CIO governed by its constitution, charity number 1166246) 

## Statement of Financial Activities 

for the year ended 31 December 2025 

|Notes<br>**Income from:**<br>Donations and legacies<br>3<br>Charitable activities<br>4<br>Trading activities<br>5<br>**Total Income**<br>**Expenditure on:**<br>Trading activities<br>6<br>Charitable activities<br>7<br>**Total Expenditure**<br>**Net income/(expenditure)**<br>**and movement in funds**<br>**Reconciliation of funds:**<br>Total funds brought forward<br>15<br>**Total funds carried forward**<br>14|**2025**<br>**2024**|**2025**<br>**2024**|
|---|---|---|
|||**icted**<br>**unds**<br>**Restricted**<br>**Funds**<br>**Total Funds**<br>**Total Funds**|
||**Unrestr**<br>**F**||
||2<br>24<br>15|£<br>£<br>£<br>£<br>8,415<br>26,000<br>54,415<br>13,868<br>6,434<br>-<br>246,434<br>191,891<br>8,044<br>-<br>158,044<br>119,048|
||**43**|**2,893**<br>**26,000**<br>**458,893**<br>**324,807**|
||2<br>34|8,230<br>-<br>28,230<br>20,495<br>4,205<br>21,667<br>365,872<br>299,915|
||**37**|**2,436**<br>**21,667**<br>**394,102**<br>**320,409**|
|||0,457<br>4,333<br>64,790<br>4,398<br>6,283)<br>-<br> (96,283)<br> (100,681)|
||6<br> (9||
||(3|5,825)<br>4,333<br> (31,492)<br> (96,283)|



All incoming resources and resources expended are derived from continuing activities The accompanying accounting policies and notes form an integral part of these financial statements. 

**9** 



## Centre for Osteopathic Research and Excellence 

(A CIO governed by its constitution, charity number 1166246) 

## Statement of Financial Position 

for the year ended 31 December 2025 

|Notes<br>**Fixed assets:**<br>Tangible assets<br>9<br>**Total fixed assets**<br>**Current assets**<br>Debtors<br>10<br>Cash at bank and in hand<br>11<br>**Total current assets**<br>**Creditors: amounts falling**<br>**due within one year**<br>12<br>**Net current assets/(liabilities)**<br>**Total assets less current liabilities**<br>**Creditors: amounts falling**<br>**due after more than one year**<br>13<br>**Total net assets**<br>**The funds of the Charity:**<br>Unrestricted funds<br>14<br>**Total charity funds**<br>16|31 December 2025|31 December 2025|31 December 2025|31 December 2024|31 December 2024|
|---|---|---|---|---|---|
||||||**£**<br>6,378|
||<br> <br> <br> <br>3|**£**<br>7,778<br>7,642|**£**<br>9,585|**£**<br> <br> <br>4,511<br>5,436||
||||9,585<br> <br> <br> <br>||6,378<br> <br> <br> <br> <br> (41,489)|
||4<br> <br>4|5,420<br>8,890||9,947<br>51,436||
|||||||
||<br> <br>||(3,470)|||
||||6,115<br> (37,608)||(35,111)<br> (61,172)|
||||(31,492)||(96,283)|
||||(31,492)||(96,283)|
||||(31,492)||(96,283)|



The financial statements were approved by the Board on 29th October 2026 and signed on its behalf by: 


**Daniyal Khan** Dated: 29th October 2026 

**10** 



## Centre for Osteopathic Research and Excellence 

(A CIO governed by its constitution, charity number 1166246) 

## Statement of Cash Flows 

for the year ended 31 December 2025 

|Net income/(expenditure) for the reporting period (as per the<br>statement of financial activities)<br>**Adjustments for:**<br>Depreciation charges<br>(Increase)/decrease in debtors<br>Increase/(decrease) in creditors<br>**Net cash provided by/(used in) operating activities**<br>**Cash flows from investing activities:**<br>Purchase of property, plant and equipment<br>**Net cash provided by/(used in) investing activities**<br>**Cash flows from financing activities:**<br>Increase/(decrease) in borrowing*<br>**Net cash provided by/(used in) financing activities**<br>**Change in cash and cash equivalents in the reporting period**<br>**Cash and cash equivalents at the beginning of the reporting**<br>**period**<br>**Cash and cash equivalents at the end of the reporting period**<br>**Analysis of cash and cash equivalents**<br>Bank and~~cash in hand~~<br>**Total cash and cash equivalents**|**2025**<br>**2024**|
|---|---|
||£<br>£<br>59,041<br>866<br>2,374<br>2,638<br>(3,090)<br>(4,339)<br> (5,034)<br> (1,830)|
||59,041<br>866<br> (5,947)<br> (169)|
||(5,947)<br>(169)|
||(21,806)<br> (7,331)|
||(21,806)<br>(7,331)<br>**31,289**<br>**(6,635)**<br>5,436<br>12,070|
||**37,642**<br>**5,436**<br>~~37,642~~<br>5,436|
||**37,642**<br>**5,436**|



*A balancing figure of £551 has been added however this amount is considered immaterial. 

**11** 



## Centre for Osteopathic Research and Excellence 

(A CIO governed by its constitution, charity number 1166246) 

## Accounting Policies 

for the year ended 31 December 2025 

## **Basis of preparation** 

The financial statements have been prepared in accordance with: 

- Applicable UK accounting standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)’. 

- Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015) - (Charities SORP FRS 102); 

- The Charities Act 2022. 

## **Public benefit entity** 

The Charity meets the criteria of a public benefit entity under FRS 102. 

## **Going concern** 

As detailed in the Trustees report, the board continues to closely monitor the financial requirements of CORE in order to deliver on our mission statement of making osteopathy available to all and is confident that we remain a financially viable going concern for the foreseeable future. 

## **Income recognition** 

Income is recognised when the Charity has a contractual or other right to its receipt, it is probable that the income will be received and that the amount can be measured reliably. Income with conditions attached to its receipt is recognised when those conditions have been fulfilled. 

Grant income is recognised on a receivable basis. 

The income from trading activities includes venue hire. Non-refundable deposits and payments received in advance are deferred to the period in which the hiring takes place. 

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Charity; this is normally upon notification of the interest paid or payable by the bank. 

## **Deferred income** 

Income received which is contractually or otherwise not expendable until a future period is deferred to the period in which it meets the criteria for income recognition. 

## **Unrestricted Funds** 

Unrestricted funds are funds received which have no restrictions placed on their use and are available as general funds. 

## **Allocation of costs** 

Costs are allocated directly to projects where they can be identified as relating solely to that project. Other costs are allocated between the funds based on staff time spent on the fund activities or other appropriate criteria. 

## **Pensions** 

The Charity operates defined contribution schemes which are administered by outside independent pensions providers. Contributions payable for the year are charged to the Statement of Financial Activities. 

## **Tangible Fixed Assets** 

Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life. 

Leasehold improvements over the period of the lease Plant & machinery 10% on cost Computer equipment 20% on cost Office equipment 20% on cost 

Assets are only capitalised where the purchase price exceeds £100. 

**12** 



## Centre for Osteopathic Research and Excellence 

(A CIO governed by its constitution, charity number 1166246) 

## Notes to the Accounts 

for the year ended 31 December 2025 

## **1 Incoming resources** 

The incoming resources and surplus are attributable to the principal activities of the Charity. 

|||||
|---|---|---|---|
|**2**<br>**Net incoming resources**<br>Net incoming resources are stated after charging:<br>Depreciation & amortisation<br>**3**<br>**Income from donations and legacies**<br>Grants & donations<br>**4**<br>**Income from charitable activities**<br>Osteopathy treatments<br>Other treatments<br>**5**<br>**Income from trading activities**<br>Events<br>Activities<br>Kitchen Let<br>Other misc revenue<br>**6**<br>**Expenditure on raising funds**<br>Fundraising<br>Events<br>Osteopathy expenses<br>Activities<br>Rental commision|**coming resources**<br>coming resources are stated after charging:<br>ciation & amortisation<br>**me from donations and legacies**<br>s & donations<br>**e from charitable activities**||**2025**<br>**2024**<br>£<br>£<br>2,374<br>37,373<br>**2025**<br>**2024**<br>**Unrestricted**<br>**Restricted**<br>**Total**<br>**Total**<br>£<br>£<br>28,415<br>26,000<br>54,415<br>13,868|
||||**28,415**<br>**54,415**<br>**13,868**<br>**2025**<br>**2024**<br>**Unrestricted**<br>**Restricted**<br>**Total**<br>**Total**<br>£<br>£<br>194,553<br>-<br>194,553<br>168,639<br>51,881<br>-<br>51,881<br>23,252|
||pathy treatments<br>treatments<br>**e from trading activities**<br>s<br>ties<br>n Let<br>misc revenue|||
||||**246,434**<br>**-**<br>**246,434**<br>**191,891**<br>**2025**<br>**2024**<br>**Unrestricted**<br>**Restricted**<br>**Total**<br>**Total**<br>£<br>£<br>108,791<br>-<br>108,791<br>83,612<br>26,265<br>-<br>26,265<br>21,746<br>15,600<br>-<br>15,600<br>13,650<br>7,388<br>-<br>7,388<br>40|
||||**158,044**<br>**-**<br>**158,044**<br>**119,048**|
|||**2025**<br>**2024**<br>**Unrestricted**<br>**Restricted**<br>**Total**<br>**Total**<br>£<br>£<br>516<br>-<br>516<br>271<br>9,546<br>-<br>9,546<br>6,465<br>1,199<br>-<br>1,199<br>1,504<br>13,435<br>-<br>13,435<br>10,378<br>3,534<br>-<br>3,534<br>1,876||
|||**28,230**<br>**-**<br>**28,230**<br>**20,495**||



**13** 



## Centre for Osteopathic Research and Excellence 

(A CIO governed by its constitution, charity number 1166246) 

## Notes to the Accounts 

for the year ended 31 December 2025 

|**2025**<br>**2024**<br>**7**<br>**Expenditure on charitable activities**<br>**Unrestricted**<br>**Restricted**<br>**Total**<br>**Total**<br>£<br>£<br>Personnel<br>246,995<br>26,000<br>272,995<br>232,718<br>Premises<br>52,704<br>52,704<br>38,265<br>Ofce expenses<br>10,014<br>10,014<br>8,145<br>CPD Costs<br>5,689<br>5,689<br>-<br>Advertising & marketing<br>14,567<br>14,567<br>8,402<br>Travel, accommodation & subsistence<br>125<br>125<br>769<br>Sundry expenses<br>60<br>60<br>600<br>Finance costs<br>5,105<br>5,105<br>4,099<br>Loan interest<br>1,339<br>1,339<br>1,853<br>Accountancy & bookkeeping<br>900<br>900<br>750<br>Consulting<br>-<br>-<br>1,675<br>Depreciation<br>2,374<br>2,374<br>2,638<br>**339,872**<br>**26,000**<br>**365,872**<br>**299,915**<br>**8**<br>**Remuneration**<br>**2025**<br>**2024**<br>Employees paid in excess of £60,000:<br>None<br>None<br>**9**<br>**Tangible fxed assets**<br>**Leasehold**<br>**improvements**<br>**Plant &**<br>**Machinery**<br>**Computer**<br>**Equipment**<br>**Ofce**<br>**Equipment**<br>**Total**<br>**Cost**<br>As of 1st January 2025<br>219,005<br>12,039<br>2,795<br>3,183<br>237,021<br>Additions<br>1,085<br>3,861<br>1,001<br>5,947<br>Disposals<br>-<br>-<br>-<br>-<br>-<br>As of 31st December 2025<br>219,005<br>13,125<br>6,655<br>4,183<br>242,968<br>**Depreciation**<br>As of 1st January 2025<br>219,005<br>6,839<br>3,011<br>2,153<br>231,009<br>Charge for the year<br>-<br>1,522<br>456<br>396<br>2,374<br>Disposals<br>-<br>-<br>-<br>-<br>-<br>**As of 31st December 2025**<br>219,005<br>8,361<br>3,468<br>2,549<br>233,383<br>**Net book value**<br>As at 31 December 2025<br>-<br>4,763<br>3,187<br>1,634<br>9,585<br>As at 31 December 2024<br>-<br>5,200<br>148<br>1,030<br>6,378|**2025**<br>**2024**<br>**7**<br>**Expenditure on charitable activities**<br>**Unrestricted**<br>**Restricted**<br>**Total**<br>**Total**<br>£<br>£<br>Personnel<br>246,995<br>26,000<br>272,995<br>232,718<br>Premises<br>52,704<br>52,704<br>38,265<br>Ofce expenses<br>10,014<br>10,014<br>8,145<br>CPD Costs<br>5,689<br>5,689<br>-<br>Advertising & marketing<br>14,567<br>14,567<br>8,402<br>Travel, accommodation & subsistence<br>125<br>125<br>769<br>Sundry expenses<br>60<br>60<br>600<br>Finance costs<br>5,105<br>5,105<br>4,099<br>Loan interest<br>1,339<br>1,339<br>1,853<br>Accountancy & bookkeeping<br>900<br>900<br>750<br>Consulting<br>-<br>-<br>1,675<br>Depreciation<br>2,374<br>2,374<br>2,638<br>**339,872**<br>**26,000**<br>**365,872**<br>**299,915**<br>**8**<br>**Remuneration**<br>**2025**<br>**2024**<br>Employees paid in excess of £60,000:<br>None<br>None<br>**9**<br>**Tangible fxed assets**<br>**Leasehold**<br>**improvements**<br>**Plant &**<br>**Machinery**<br>**Computer**<br>**Equipment**<br>**Ofce**<br>**Equipment**<br>**Total**<br>**Cost**<br>As of 1st January 2025<br>219,005<br>12,039<br>2,795<br>3,183<br>237,021<br>Additions<br>1,085<br>3,861<br>1,001<br>5,947<br>Disposals<br>-<br>-<br>-<br>-<br>-<br>As of 31st December 2025<br>219,005<br>13,125<br>6,655<br>4,183<br>242,968<br>**Depreciation**<br>As of 1st January 2025<br>219,005<br>6,839<br>3,011<br>2,153<br>231,009<br>Charge for the year<br>-<br>1,522<br>456<br>396<br>2,374<br>Disposals<br>-<br>-<br>-<br>-<br>-<br>**As of 31st December 2025**<br>219,005<br>8,361<br>3,468<br>2,549<br>233,383<br>**Net book value**<br>As at 31 December 2025<br>-<br>4,763<br>3,187<br>1,634<br>9,585<br>As at 31 December 2024<br>-<br>5,200<br>148<br>1,030<br>6,378|**2025**<br>**2024**<br>**7**<br>**Expenditure on charitable activities**<br>**Unrestricted**<br>**Restricted**<br>**Total**<br>**Total**<br>£<br>£<br>Personnel<br>246,995<br>26,000<br>272,995<br>232,718<br>Premises<br>52,704<br>52,704<br>38,265<br>Ofce expenses<br>10,014<br>10,014<br>8,145<br>CPD Costs<br>5,689<br>5,689<br>-<br>Advertising & marketing<br>14,567<br>14,567<br>8,402<br>Travel, accommodation & subsistence<br>125<br>125<br>769<br>Sundry expenses<br>60<br>60<br>600<br>Finance costs<br>5,105<br>5,105<br>4,099<br>Loan interest<br>1,339<br>1,339<br>1,853<br>Accountancy & bookkeeping<br>900<br>900<br>750<br>Consulting<br>-<br>-<br>1,675<br>Depreciation<br>2,374<br>2,374<br>2,638<br>**339,872**<br>**26,000**<br>**365,872**<br>**299,915**<br>**8**<br>**Remuneration**<br>**2025**<br>**2024**<br>Employees paid in excess of £60,000:<br>None<br>None<br>**9**<br>**Tangible fxed assets**<br>**Leasehold**<br>**improvements**<br>**Plant &**<br>**Machinery**<br>**Computer**<br>**Equipment**<br>**Ofce**<br>**Equipment**<br>**Total**<br>**Cost**<br>As of 1st January 2025<br>219,005<br>12,039<br>2,795<br>3,183<br>237,021<br>Additions<br>1,085<br>3,861<br>1,001<br>5,947<br>Disposals<br>-<br>-<br>-<br>-<br>-<br>As of 31st December 2025<br>219,005<br>13,125<br>6,655<br>4,183<br>242,968<br>**Depreciation**<br>As of 1st January 2025<br>219,005<br>6,839<br>3,011<br>2,153<br>231,009<br>Charge for the year<br>-<br>1,522<br>456<br>396<br>2,374<br>Disposals<br>-<br>-<br>-<br>-<br>-<br>**As of 31st December 2025**<br>219,005<br>8,361<br>3,468<br>2,549<br>233,383<br>**Net book value**<br>As at 31 December 2025<br>-<br>4,763<br>3,187<br>1,634<br>9,585<br>As at 31 December 2024<br>-<br>5,200<br>148<br>1,030<br>6,378|**2025**<br>**2024**<br>**Unrestricted**<br>**Restricted**<br>**Total**<br>**Total**<br>£<br>£|**2025**<br>**2024**<br>**Unrestricted**<br>**Restricted**<br>**Total**<br>**Total**<br>£<br>£|
|---|---|---|---|---|
|||||246,995<br>26,000<br>272,995<br>232,718<br>52,704<br>52,704<br>38,265<br>10,014<br>10,014<br>8,145<br>5,689<br>5,689<br>-<br>14,567<br>14,567<br>8,402<br>125<br>125<br>769<br>60<br>60<br>600<br>5,105<br>5,105<br>4,099<br>1,339<br>1,339<br>1,853<br>900<br>900<br>750<br>-<br>-<br>1,675<br>2,374<br>2,374<br>2,638|
||nnel<br>ses<br>expenses<br>osts<br>tising & marketing<br>, accommodation & subsistence<br>y expenses<br>ce costs<br>nterest<br>untancy & bookkeeping<br>lting<br>ciation||||
|||||**339,872**<br>**26,000**<br>**365,872**<br>**299,915**<br>**2025**<br>**2024**<br>None<br>None<br>**Plant &**<br>**chinery**<br>**Computer**<br>**Equipment**<br>**Ofce**<br>**Equipment**<br>**Total**<br>12,039<br>2,795<br>3,183<br>237,021<br>1,085<br>3,861<br>1,001<br>5,947<br>-<br>-<br>-<br>-|
||**neration**<br>yees paid in excess of<br>**ble fxed assets**<br>1st January 2025<br>ons<br>sals|£60,000:<br>**Leasehold**<br>**improvements**<br>**Ma**<br>219,005<br>-|||
||||||
|||219,005<br>13,125<br>6,655<br>4,183<br>242,968<br>219,005<br>6,839<br>3,011<br>2,153<br>231,009<br>-<br>1,522<br>456<br>396<br>2,374<br>-<br>-<br>-<br>-<br>-|||
|||219,005<br>8,361<br>3,468<br>2,549<br>233,383<br>-<br>4,763<br>3,187<br>1,634<br>9,585|||
|||-<br>5,200<br>148<br>1,030<br>6,378|||



**14** 



## Centre for Osteopathic Research and Excellence 

(A CIO governed by its constitution, charity number 1166246) 

## Notes to the Accounts 

for the year ended 31 December 2025 

|**10**<br>**Debtors: amounts falling due within one year**<br>Accounts receivable<br>Accrued Income<br>Prepayments<br>Rent deposit<br>Treatwell<br>**11**<br>**Bank and cash in hand**<br>Charity bank account<br>PayPal<br>Stripe<br>Petty cash<br>Cash in hand<br>**12**<br>**Creditors: amounts falling due within one year**<br>Accounts payable<br>Bounce back loan<br>Hall hire in advance<br>Income in advance<br>Income in advance (CPD)<br>Other accruals<br>Other creditors<br>Payroll taxes<br>Pensi~~ons payable~~<br>Refundable deposits<br>Rent accruals<br>Restricted Grants<br>**13**<br>**Creditors: amounts falling due afer one year**<br>Bounce back loan<br>Social investment loans|**2025**<br>**2024**<br>£<br>£<br>3,131<br>768<br>-<br>727<br>3,958<br>3,015<br>550<br>-<br>140<br>-|
|---|---|
||**7,778**<br>**4,511**<br>**2025**<br>**2024**<br>£<br>£<br>35,062<br>4,342<br>302<br>903<br>1,593<br>141<br>9<br>-<br>675<br>50|
||**37,642**<br>**5,436**<br>**2025**<br>**2024**<br>£<br>£<br>12,620<br>12,743<br>6,250<br>6,250<br>2,410<br>2,350<br>3,025<br>2,809<br>2,630<br>-<br>13,952<br>10,348<br>-<br>268<br>1,276<br>5,603<br>~~1,094~~<br>827<br>1,300<br>2,600<br>-<br>7,638<br>4,333<br>-|
||**48,890**<br>**51,436**<br>**2025**<br>**2024**<br>£<br>£<br>29,392<br>35,890<br>8,215<br>25,282|
||**37,608**<br>**61,172**|



**15** 



## Centre for Osteopathic Research and Excellence 

(A CIO governed by its constitution, charity number 1166246) 

## Notes to the Accounts 

for the year ended 31 December 2025 

|**14**|**The funds of the Charity: 2025**||||||
|---|---|---|---|---|---|---|
|||Opening|Resources|Resources|Other|Closing|
|||balance|arising|utilised|movements|balance|
|||£|£|£|£|£|
||Unrestricted funds|(96,283)|432,893|(372,435)||(35,825)|
||Restricted funds|-|26,000|(21,667)||4,333|
|||(96,283)|458,893|(394,102)|-|(31,492)|
|**15**|**The funds of the Charity: 2024**||||||
|||Opening|Resources|Resources|Other|Closing|
|||balance|arising|utilised|movements|balance|
|||£|£|£|£|£|
||Unrestricted funds|(100,681)|324,807|(320,409)||(96,283)|
|||(100,681)|324,807|(320,409)||(96,283)|
|**16**|**Net assets attributable to funds:**|**2025**|||||
|||Unrestricted|Designated|Restricted|Endowment||
|||funds|funds|funds|funds|Total|
|||£|£|£|£|£|
||Tangible fxed assets|9,585|-|-|-|9,585|
||Current assets|45,420|-|-|-|45,420|
||Current liabilities|(44,557)|-|(4,333)|-|(48,890)|
||Long term liabilities|(37,608)||||(37,608)|
||Net assets attributed to funds|(27,160)|-|(4,333)|-|(31,492)|
|**17**|**Net assets attributable to funds:**|**2024**|||||
|||Unrestricted|Designated|Restricted|Endowment||
|||funds|funds|funds|funds|Total|
|||£|£|£|£|£|
||Tangi~~ble fxed assets~~|~~6,378~~|~~-~~|~~-~~|~~-~~|6,378|
||Current assets|9,947|-|-|-|9,947|
||Current liabilities|(51,435)|-|-|-|(51,435)|
||Long term liabilities|(61,172)|-|-|-|(61,172)|
||Net assets attributed to funds|(96,283)|-|-|-|(96,283)|



**16** 



## Centre for Osteopathic Research and Excellence 

(A CIO governed by its constitution, charity number 1166246) 

## Notes to the Accounts 

for the year ended 31 December 2025 

## **18 Adjustments to previously filed accounts** 

Any adjustments for the previous period are considered immaterial and therefore not highlighted. 

## **19 Taxation** 

The organisation is a registered charity. Accordingly, it is exempt from taxation in respect of income and capital gains to the extent that these are applied to its charitable objects. 

## **20 Other financial commitments** 

The Charity had no other financial commitments at 31 December 2025 nor, at 31 December 2024 

## **21 Contingent liabilities** 

The Charity had no material contingent liabilities at 31 December 2025 nor, at 31 December 2024. 

## **22 Related parties** 

During the year the Charity used the financial and bookkeeping services of Patrick Orchard, who is the brother of Daniel Orchard, CEO and a trustee during the period. All services were provided on arms-length terms. 

## **23 Transactions with trustees** 

During the financial year Daniel Orchard, who stepped down as Trustee in August 2025, was paid £52,000 (2024: £40,625). 

Payments were made in respect of his capacity as CEO and manager of the site and not for his service as a trustee. 

## **24 Gifts in kind and volunteers** 

During the year the Charity benefited from unpaid work performed by volunteers. 

## **25 Statutory status** 

The organisation is a charitable incorporated organisation. 

**17** 

